131
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
(No reviews yet)
Write a Review
- SKU:
- 131-BR1503d-GEN
- Availability:
- IN STOCK
Description
Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e
Related Products
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1504c
131
$1,396.50
Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced...
131-BR1504b-GEN
Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1505d
131
$1,396.50
Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced by BR1505d
131-BR1505c-GEN
Breast cancer tissue array, including pathology grade, IHC markers (ER, PR, Her-2) results, 4 cases/8 cores, replaced by BR082c
131
$721.00
Breast cancer tissue array, including pathology grade, IHC markers (ER, PR, Her-2) results, 4 cases/8 cores, replaced by BR082c
131-BR082b-GEN
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e
131
$1,396.50
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e
131-BR1503f-GEN
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
131
$721.00
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
131-PM2a-ER-GEN